Navigation Links
Genomic Health Announces First Quarter 2011 Financial Results and Business Progress
Date:5/3/2011

r the same period in 2010 of $4.3 million.

Cash and cash equivalents and investments in marketable securities at March 31, 2011 were $76.6 million compared with $76.8 million at December 31, 2010.

In the first quarter of 2011, more than 16,230 Oncotype DX test results were delivered, an increase of 22 percent compared with more than 13,310 test results delivered in the first quarter of 2010.

The company maintains financial guidance for the full-year ending December 31, 2011:

  • Total revenue of $200 to $210 million
  • Full-year net income of $3 to $5 million
  • Oncotype DX test results delivered of 63,000 to 66,000

  • Quarterly HighlightsOncotype DX Breast Cancer Commercial Progress

  • Secured reimbursement for estrogen-receptor positive breast cancer patients with one to three positive nodes with Excellus, a payor covering 1.8 million lives in New York. 
  • Increased covered lives outside of the United States to more than 42 million through reimbursement arrangements now including payors and institutions in Canada, Germany, Greece, Ireland, Israel, Mexico, Spain, Venezuela and the United Kingdom.
  • AOK Rheinland/Hamburg, a national health insurance provider in Germany, announced it will reimburse Oncotype DX as part of a treatment study being conducted by the West German Study Group.
  • Initiated a decision impact study of Oncotype DX in Australia.
  • Launched a Spanish language version of the Oncotype DX breast cancer website.
  • Established a distribution agreement to provide the Oncotype DX breast and colon cancer tests in South Africa, Botswana, Namibia, and Kenya.

  • Oncotype DX Colon Cancer Commercial Progress

  • Partnered with the advocacy organization, Fight Colore
    '/>"/>

  • SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
    2. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
    3. Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
    4. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
    5. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
    6. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
    7. Researchers use genomics to investigate TB outbreak
    8. Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
    9. Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
    10. Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically Available Rat Genome Database
    11. Four Community Hospitals Join DNA Directs Genomic Medicine Network
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/21/2014)... , Nov. 21, 2014   TRU-D SmartUVC LLC ... feature their superbug-killing UVC automated disinfection robot, TRU-D SmartUVC, at ... week from Nov. 23 to 26 at Stand 23. ... the United Kingdom,s largest infection-related event ... prevention societies to one of the leading events of its ...
    (Date:11/21/2014)... CA (PRWEB) November 20, 2014 Offering ... their Sartorius Entris Balance promotion . The Sartorius ... seeking a durable, high accuracy, and easy-to-maintain balance entry ... in Germany. It was designed to help customer’s bridge ... and a balance that is very durable. Sartorius is ...
    (Date:11/21/2014)... 20, 2014 The California ... research organization representing leading California academic institutions, biotechnology, ... PwC US today released a report revealing ... industry growth. The trend shows a 4 percent ... California Biomedical Industry Report indicates that, while ...
    (Date:11/21/2014)... York, NY (PRWEB) November 20, 2014 ... is now available as an open access journal featuring ... with infrared fluorescent proteins to preserve photoresponsiveness in the ... Two-color fluorescent in situ hybridization using chromogenic substrates ... chips for DNA, RNA, and protein electrophoresis , ...
    Breaking Biology Technology:TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 2TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 3Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3
    ... Nov. 12 WHO and CDC have stated that ... is "suboptimal" -- often correct less than 50% of ... are not yet accurate in,our predictions of upcoming influenza ... the United States alone., As in the case ...
    ... China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo,Pharmaceutical ... Shenghuo" or the,"Company"), which is engaged in ... nutritional supplement and cosmetic products,in the People,s ... NYSE Alternext,US LLC (formerly the American Stock ...
    ... (ASX: POH; OTCQX: PPGNY) announced today that ... trial using its patented drug,delivery system, TPM, ... non steroidal,anti-inflammatory drug (NSAID), diclofenac. The trial ... topically applied Voltaren(R) gel,(1% diclofenac), one of ...
    Cached Biology Technology:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 4Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans 2
    (Date:11/7/2014)...  In conjunction with the Glendale ... Foundation of the Verdugos has announced the " GLENDALE ... $250,000 initiative to keep the Verdugo Regional Crime Lab operational ... months of existence, the Lab has processed more than 400 ... enforcement. "Because our number one priority is the ...
    (Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
    (Date:11/4/2014)... of death at the right time might actually help ... that could help in understanding animal populations, pest control ... paper in the journal Trends in Ecology and ... conclude that the kind of positive population effect an ... mortality, depends on the size and developmental stage of ...
    Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
    ... CAMBRIDGE, Mass. -- MIT biological engineers have developed a ... that have undergone a specific mutation. The work, ... marks the first time researchers have been able to ... a particular mutationin intact tissue. In this case, the ...
    ... of mangroves on the coasts of the Philippines could help ... that hit the islands annually. This is one of ... massive mangrove replanting, that J.H. Primavera from the Southeast Asian ... University, both in the Philippines, cite in a paper published ...
    ... soon as it,s begun promises to reduce the need for ... & Industry (C&I) magazine. Drilling is one ... off visiting their dentist every year. The new ... years from now, is based on Raman spectroscopy most commonly ...
    Cached Biology News:MIT researchers offer glimpse of rare mutant cells 2Mangroves key to saving lives 2End in sight for the dreaded dentist drill 2
    streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
    Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
    RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
    ...
    Biology Products: